134 filings
Page 6 of 7
8-K
7fwrtfz 5g04
17 Dec 14
Other Events
12:00am
8-K
r78tceh40v78su
11 Dec 14
OvaScience Strengthens Management Team to Support Expanding
12:00am
8-K
bgdqudp
10 Nov 14
OvaScience Reports Third Quarter 2014 Financial Results
12:00am
8-K
mqu 3kqkruns1rt1ow
18 Sep 14
OvaScience Appoints Jeffrey Young to Chief Financial Officer
12:00am
8-K
a2vru q7dwjpo7yo
7 Aug 14
OvaScience Reports Second Quarter 2014 Financial Results
12:00am
8-K
e7d39xbl1mwqjgoqpde4
19 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
f019 adryw
8 May 14
OvaScience Reports First Quarter 2014 Financial Results
12:00am
8-K
2ahbx03kbht
18 Mar 14
OvaScience Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
12:00am
8-K
8sbjpibhrnzxilvvtp
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
8hbifo sd
27 Feb 14
OvaScience Reports Fourth Quarter and Year End 2013 Financial Results
12:00am
8-K
bdwk avc3ltla0yr8t
7 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
yn2un5o
13 Jan 14
OvaScience Provides Update on Pipeline Advancements and Commercial Plans
12:00am
8-K
ucso5
13 Jan 14
OvaScience Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board of Directors
12:00am
8-K
5kj6kha
9 Jan 14
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
12:00am
8-K
mzxwcrc
19 Dec 13
OvaScience and Intrexon Collaborate to Accelerate Development of OvaScience’s OvaTureSM Technology for Infertility Treatments
12:00am
8-K
1b9it24luzdbllnpzxj9
13 Nov 13
OvaScience Reports Third Quarter Fiscal 2013 Financial Results
12:00am
8-K
5lcb1e0f
11 Sep 13
OvaScience Provides Update on AUGMENTSM
12:00am
8-K
j5a2cch1p7pm0y
13 Aug 13
OvaScience Reports Second Quarter Fiscal 2013 Financial Results
12:00am
8-K
jmgphq
30 Jul 13
OvaScience Appoints Arthur Tzianabos, Ph.D., to Chief Scientific Officer
12:00am
8-K
u5m37m7w b7ncmi
2 Jul 13
Departure of Directors or Certain Officers
12:00am